Pharmaco - Press Releases

Date	Title	Company
15-Dec-2021	Immatics and Bristol Myers Squibb Enter Into Global Exclusive License for Immatics’ TCR Bispecific Program IMA401	Bristol Myers Squibb
15-Dec-2021	PFIZER ANNOUNCES ADDITIONAL PHASE 2/3 STUDY RESULTS CONFIRMING ROBUST EFFICACY OF NOVEL COVID-19 ORAL ANTIVIRAL TREATMENT CANDIDATE IN REDUCING RISK OF HOSPITALIZATION OR DEATH	Pfizer
15-Dec-2021	XPhyto Therapeutics Corp.: XPhyto Epilepsy Clinical Trial Planned in 2022 with Its Proprietary Fast-Dissolving CBD Oral Strips	XPhyto Therapeutics Corp.
15-Dec-2021	SciRhom Establishes a World-Class Clinical Advisory Board	B3C newswire
15-Dec-2021	Polyphor and EnBiotix announce dosing of first patient in a first-in-human clinical trial of inhaled murepavadin	Polyphor AG
15-Dec-2021	Relief Reports that U.S. Collaboration Partner Announces New, Favorable Safety Report for Aviptadil in NIH Sponsored ACTIV-3b Critical Care Study in Patients with Life-Threatening COVID-19	RELIEF THERAPEUTICS Holding AG
14-Dec-2021	Medacta Launches 360° (Anterior and Posterior) Cervical Platform, Highlighting MySpine Cervical, a Further Enhancement to the MySolutions Personalized Ecosystem	Medacta Group SA
14-Dec-2021	Medios AG: Planned takeover of NewCo Pharma Group approved by Cartel Office	Medios AG
14-Dec-2021	sterna biologicals announces dosing of first patient in phase IIa proof-of-concept study with SB010 in moderate to severe asthma	sterna biologicals GmbH & Co. KG
14-Dec-2021	Pfizer to Acquire Arena Pharmaceuticals	Pfizer
14-Dec-2021	Lilly and Foghorn Announce Strategic Collaboration for Novel Oncology Targets Using Foghorn's Proprietary Gene Traffic Control® Platform	Lilly
14-Dec-2021	MS Pharma becomes Partner for the Commercialization of FYB201, Formycon's Biosimilar Candidate to Lucentis(R)1 (ranibizumab), in the MENA Region	Formycon AG
14-Dec-2021	APONTIS PHARMA and Midas Pharma announce development partnership to launch Single Pill with pan-European intellectual property rights	APONTIS PHARMA AG
14-Dec-2021	Supervisory Board of Epigenomics AG appoints Jens Ravens as Chief Financial Officer	Epigenomics AG
14-Dec-2021	Biotest AG: Biotest treats first CMV-positive pregnant woman in Phase III clinical trial to prevent transmission of CMV infection to the unborn child	Biotest AG
13-Dec-2021	Akoya Biosciences Announces a Groundbreaking Collaboration with PathAI to Combine Spatial Biology with AI-Powered Tools to Facilitate Discovery of Novel Predictive Biomarkers	Akoya Biosciences
13-Dec-2021	Calquence reduced the risk of disease progression or death by 71% vs. standard of care combinations at three years in the ASCEND Phase III trial	AstraZeneca
13-Dec-2021	PFIZER AND SANGAMO ANNOUNCE UPDATED PHASE 1/2 RESULTS SHOWING SUSTAINED BLEEDING CONTROL IN HIGHEST DOSE COHORT THROUGH TWO YEARS FOLLOWING HEMOPHILIA A GENE THERAPY	PFIZER
13-Dec-2021	Novo Nordisk invests more than DKK 17 bn in expansion of the manufacturing facilities in Kalundborg, Denmark	Novo Nordisk
13-Dec-2021	DEFENCE THERAPEUTICS ACCUMTM BOOSTS BY 9-FOLD THE DELIVERY EFFECTIVENESS OF THE CRISPR/CAS9 PROTEIN TO TARGET CELLS	Defence Therapeutics Inc.